BioSpace News Archive

Business

BioSpace Movers & Shakers, May 8

Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

May 7, 2020
·
5 min read
·
Alex Keown
Drug Development

Analysts: COVID-19 May Have a Lasting Effect on Drug Development

As the world continues to grapple with the effects of the COVID-19 pandemic, healthcare analysts are starting to wonder how the outbreak will impact drug development.

May 7, 2020
·
3 min read
·
Krystle Vermes
Pharm Country

BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced a lease agreement with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel, to produce NurOwn® in three state-of-the-art cleanrooms.

May 7, 2020
·
5 min read
Biotech Bay

New Data at the ASCO20 Virtual Scientific Program Reflects Genentech’s Commitment to Accelerating Progress in Cancer Care

First clinical data from tiragolumab, Genentech’s novel anti-TIGIT cancer immunotherapy, in combination with Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer (NSCLC)

May 7, 2020
·
19 min read
Business

Photocure ASA: Results for the First Quarter of 2020

Photocure ASA announced the first quarter 2020 results in the trading update 27 April 2020, stating a revenue growth of 33% for the U.S.

May 7, 2020
·
6 min read
Drug Development

Results From Pivotal Phase 2/3 Study of Emapalumab in Patients With Primary HLH Published in New England Journal of Medicine

Sobi™ announced that the results from the pivotal phase 2/3 study evaluating the efficacy and safety of emapalumab in patients with primary haemophagocytic lymphohistiocytosis were published in the New England Journal of Medicine on 7 May 2020.

May 7, 2020
·
5 min read
Policy

TWi Biotechnology Receives Canada Health Approval for AC-1101 Phase 1 CTA

TWi Biotechnology announced that they have received Clinical Trial Application approval from the Health Canada to conduct a Phase 1 clinical trial with AC-1101 gel.

May 7, 2020
·
1 min read
Business

InDex Pharmaceuticals Holding AB (publ) Interim Report January - March 2020

FDA and EMA endorse the advancement of cobitolimod into phase III studies

May 7, 2020
·
5 min read
Tissue Diagnostics Market - Key Growth Factors and Prominent Trends Report Study to 2029

Rising prevalence of cancer is one the major factors driving growth of tissue diagnostic market.

May 7, 2020
·
4 min read
Recombinase Polymerase Amplification Market Growth and Restrain Factors Study Analysis

Recombinase Polymerase Amplification is a new isothermal method to amplify the DNA as well as RNA.

May 7, 2020
·
5 min read